GLS2 and breast cancer: The current study evaluated the transcriptomic and proteomic expression of GLS and GLS2 and their association with various clinicopathological parameters and linked each biomarker to the patient outcome to provide an understanding of the prognostic significance of GLS and GLS2 in BC.